{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:27:17Z","timestamp":1786472837640,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1053\/j.ajkd.2006.08.004","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T11:05:03Z","timestamp":1170759903000},"page":"739-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial"],"prefix":"10.1053","volume":"48","author":[{"given":"Keith","family":"Norris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacque","family":"Bourgoigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otelio","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Rostand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jackson T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2006.08.004_bib1","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2006.08.004_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.004_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2006.08.004_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0272-6386(03)00405-0","article-title":"Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP)","volume":"42","author":"Brown","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2006.08.004_bib8","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.004_bib9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2006.08.004_bib10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.004_bib11","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2006.08.004_bib12","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.004_bib13","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.004_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"Berl","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.004_bib18","first-page":"1100","article-title":"Cox\u2019s regression model for counting processes: A large sample study","volume":"10","author":"Anderson","year":"1982","journal-title":"Ann Stat"},{"key":"10.1053\/j.ajkd.2006.08.004_bib19","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.004_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial [erratum in Lancet 361:1230, 2003]","volume":"361","author":"Nakao","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2006.08.004_bib21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","article-title":"Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction","volume":"344","author":"Exner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib22","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2006.08.004_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.004_bib24","first-page":"17","article-title":"The relationship between urinary cations obtained from the INTERSALT Study and cerebrovascular mortality","volume":"6","author":"Xie","year":"1992","journal-title":"J Hum Hypertens"},{"key":"10.1053\/j.ajkd.2006.08.004_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9629(15)40497-5","article-title":"What is the role of dietary sodium and potassium in hypertension and target organ injury?","volume":"317","author":"He","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.ajkd.2006.08.004_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0272-6386(03)00742-X","article-title":"Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study","volume":"42","author":"Romundstad","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2006.08.004_bib27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/diab.44.11.1303","article-title":"Albuminuria and poor glycemic control predict mortality in NIDDM","volume":"44","author":"Gall","year":"1995","journal-title":"Diabetes"},{"key":"10.1053\/j.ajkd.2006.08.004_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.004_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American Study of Kidney Disease and Hypertension","volume":"165","author":"Lea","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0272-6386(12)80946-2","article-title":"US minority groups and end-stage renal disease: A disproportionate share","volume":"19","author":"Rostand","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2006.08.004_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1523-1755.2003.00138.x","article-title":"To have and have not: Health and health care disparities in chronic kidney disease","volume":"64","author":"Powe","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.004_bib32","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/01.ASN.0000026493.18542.6A","article-title":"Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors","volume":"13","author":"Tarver-Carr","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2006.08.004_bib33","first-page":"CR466","article-title":"Educational attainment and risk of stroke and myocardial infarction","volume":"9","author":"Qureshi","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1053\/j.ajkd.2006.08.004_bib34","series-title":"Heart Disease and Stroke Statistics\u20142005 Update","year":"2005"},{"key":"10.1053\/j.ajkd.2006.08.004_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0895-7061(97)00162-3","article-title":"Higher education and income are related to a better Na:K ratio in blacks: Baseline results of the Treatment of Mild Hypertension Study (TOMHS) data","volume":"10","author":"Ganguli","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1053\/j.ajkd.2006.08.004_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1997.00440280091008","article-title":"Educational attainment, anger, and the risk of triggering myocardial infarction onset","volume":"157","author":"Mittleman","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.PSY.0000107909.74904.3D","article-title":"Low educational attainment, John Henryism, and cardiovascular reactivity to and recovery from personally relevant stress","volume":"66","author":"Merritt","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1053\/j.ajkd.2006.08.004_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1037\/0278-6133.22.3.300","article-title":"Chronic stress burden, discrimination, and subclinical carotid artery disease in African American and Caucasian women","volume":"22","author":"Troxel","year":"2003","journal-title":"Health Psychol"},{"key":"10.1053\/j.ajkd.2006.08.004_bib39","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.287.12.1548","article-title":"Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis","volume":"287","author":"Klassen","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2006.08.004_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2006.08.004_bib41","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1161\/01.CIR.0000149806.01354.BF","article-title":"Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: The Survival and Ventricular Enlargement (SAVE) Study","volume":"110","author":"Tokmakova","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2006.08.004_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.CIR.0000158131.78881.D5","article-title":"Race and renal impairment in heart failure: Mortality in blacks versus whites","volume":"111","author":"Smith","year":"2005","journal-title":"Circulation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638606013035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638606013035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:45:57Z","timestamp":1759455957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638606013035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0272638606013035"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2006.08.004","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2006.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}